Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peritoneal Ultrafiltration in Cardio Renal Syndrome to Prevent Heart Failure Exacerbation.

NCT03994874 is registered in ClinicalTrials.gov with Iperboreal Pharma Srl as lead sponsor.

NCT NCT03994874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peritoneal Ultrafiltration in Cardio Renal Syndrome to Prevent Heart Failure Exacerbation.
Lead sponsor
Iperboreal Pharma Srl
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 16, 2025
Completion date
June 30, 2027
Enrollment
84 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure